Poll: What to do when peer review feels inadequate?

Imagine via Raul Pacheco-Vega
Image via Raul Pacheco-Vega

How should scientists think about papers that have undergone what appears to be a cursory peer review? Perhaps the papers were reviewed in a day — or less — or simply green-lighted by an editor, without an outside look. That’s a question Dorothy Bishop, an Oxford University autism researcher, asked herself when she noticed some troubling trends in four autism journals.

Recently, Bishop sparked a firestorm when she wrote several blog posts arguing that these four autism journals had a serious problem. For instance, she found that Johnny Matson, then-editor of Research in Developmental Disabilities and Research in Autism Spectrum Disorders, had an unusually high rate of citing his own research – 55% of his citations are to his own papers, according to Bishop. Matson also published a lot in his own journals – 10% of the papers published in Research in Autism Spectrum Disorders since Matson took over in 2007 have been his. Matson’s prodigious self-citation in Research in Autism Spectrum Disorders was initially pointed out by autism researcher Michelle Dawson, as noted in Bishop’s original post.

Short peer reviews of a day or less were also common. Matson no longer edits the journals, both published by Elsevier.

Bishop noted similar findings at Developmental Neurorehabilitation and Journal of Developmental and Physical Disabilities, where the editors (and Matson) frequently published in each others’ journals, and they often had short peer reviews: The median time for Matson’s papers in Developmental Neurorehabilitation between 2010 and 2014 was a day, and many were accepted the day they were submitted, says Bishop.

Although this behavior may seem suspect, it wasn’t necessarily against the journals’ editorial policies. This is the peer review policy at RIDD:

Continue reading Poll: What to do when peer review feels inadequate?

BioMed Central retracting 43 papers for fake peer review

bmc logoBioMed Central is retracting 43 papers, following their investigation into 50 papers that raised suspicions of fake peer review, possibly involving third-party companies selling the service.

In November 2014 we wrote about fake peer reviews for Nature; at that point there had been about 110 retractions across several journals. The addition of 16 retractions by Elsevier for the same reason, and today’s 43 from BMC, brings retractions resulting from the phenomenon up to about 170.

BMC has also contacted institutions regarding 60 additional papers that were rejected for publication, but seem to be part of the same kind of scam. Regarding the third-party agents, BMC senior editor of scientific integrity Elizabeth Moylan writes: Continue reading BioMed Central retracting 43 papers for fake peer review

David Vaux: Nature’s decision to add double-blind peer review is good, but could be better

David Vaux, a cell biologist at the Walter + Eliza Hall Institute of Medical Research in Melbourne, explains how Nature could do more to remove bias from the peer review process. He previously wrote about his decision to retract a paper.

vaux
David Vaux

Last week, Nature announced that they are to offer authors of papers submitted to Nature or the monthly Nature research journals the option of having their manuscripts assessed by double-blind peer review, in which reviewers are blinded to the identity of authors and their institutions. Until now, papers sent to Nature, and most other journals, have been reviewed by a single-blind process, in which the reviewers know the identities and affiliations of the authors, but the authors are not told who the reviewers are. The goal of double-blind peer review is for submitted papers to be judged on their scientific merit alone, and thus to reduce publication bias.

While Nature should be applauded for this move, the way they have implemented it leaves room for improvement.

Continue reading David Vaux: Nature’s decision to add double-blind peer review is good, but could be better